Search

Search Constraints

You searched for: Author/Creator Pul, Refik

Search Results

1. Monocyte/macrophage lineage commitment and distribution are affected by the lack of regulatory T cells in scurfy mice. Issue 7 (27th May 2016)

2. Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells. (11th December 2018)

6. Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19. Issue 5 (September 2021)

7. Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease: CHANCENMO Study. (15th March 2022)

8. CDP-choline is not protective in the SOD1-G93A mouse model of ALS. Issue 4 (1st May 2013)

9. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

10. Importance of Follow-Up Cerebrospinal Fluid Analysis in Cryptococcal Meningoencephalitis. (13th October 2014)